AstraZeneca

 Data indicates 3rd dose of AstraZeneca helps against Omicron

eAwaz Medicine

London (Reuters) – AstraZeneca (AZN.L) said that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose.